DNA RNA and Cells

06 Feb 2020 Calibr’s ‘switchable’ CAR-T platform for cancer moves forward with FDA clearance of Investigational New Drug application
06 Feb 2020 Arrowhead Reports Interim Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3
04 Feb 2020 AskBio Announces First Patient Dosed in Phase 1 Trial Using AAV Gene Therapy for Congestive Heart Failure
04 Feb 2020 Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660
04 Feb 2020 HGF Gene Therapy Product Collategene AnGes Inc. initiated Phase 2b study in the U.S. in patients with lower limb ischemic ulcers
03 Feb 2020 Avacta and Daewoong Agree Collaboration and License Agreement with AffyXell Therapeutics
03 Feb 2020 Cardior Pharmaceuticals Demonstrates Reversal of Heart Failure with Lead Compound CDR132L
02 Feb 2020 Alnylam Receives Positive CHMP Opinion for GIVLAARI™ (givosiran) for the Treatment of Acute Hepatic Porphyria in Adults and Adolescents
30 Jan 2020 SQZ Biotech Announces First Patient Dosed in Phase 1 Trial of SQZ-PBMC-HPV for HPV+ Tumors
30 Jan 2020 Autolus Therapeutics Presents Encouraging Additional Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers
30 Jan 2020 miRagen Therapeutics Announces Positive Data for Cobomarsen in Adult T-Cell Leukemia/lymphoma Patients With Residual Disease
30 Jan 2020 Rubius Therapeutics Announces First Patient Dosed in Phase 1b Trial of RTX-134 for the Treatment of Patients with Phenylketonuria
30 Jan 2020 Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Development for Coronavirus Infection
30 Jan 2020 European Medicines Agency Validates Kite’s Marketing Application for Company’s Second CAR T Cell Therapy
30 Jan 2020 Unum Therapeutics Provides Updates to its Phase 1 Trial of ACTR707 for HER2+ Solid Tumor Cancers
29 Jan 2020 Akcea and Ionis report positive topline phase 2 study results of AKCEA-ANGPTL3-LRx
29 Jan 2020 Seelos Therapeutics Announces Update to Parkinson’s Disease Program SLS-007
27 Jan 2020 TILT Biotherapeutics Signs a Licensing Deal with Biotheus, Inc for Cancer Therapy with Oncolytic Virus TILT-123
25 Jan 2020 Bellicum Presents New Translational Data for BPX-601 at ASCO GI Cancers Symposium
25 Jan 2020 Ervaxx and Cardiff University Enter Collaboration to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens™
25 Jan 2020 Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV
22 Jan 2020 Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx
22 Jan 2020 Celularity Announces FDA Clearance of Landmark IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy
22 Jan 2020 Targovax Announces Encouraging Data in Mesothelioma Study Combining ONCOS-102 and Standard of Care Chemotherapy
22 Jan 2020 PDC*line Pharma raises €20 million in Series B financing round

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up